Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report

By Rizzoli R.   Åkesson K.   Bouxsein M.   Kanis J.   Napoli N.   Papapoulos S.   Reginster J.-Y.   Cooper C.  

Osteoporosis International, Vol. 22, Iss. 2, 2011-02 ,pp. : 373-390

Springer Publishing Company

Access to resources Recommend Favorite

Long-term raloxifene for postmenopausal osteoporosis

By Recker Robert R.   Mitlak Bruce H.   Ni Xiao   Krege John H.  

Current Medical Research and Opinion, Vol. 27, Iss. 9, 2011-09 ,pp. : 1755-1761

Informa Healthcare

Access to resources Recommend Favorite

Prevalence of osteoporosis and the use of bone protective therapies in dermatology clinic patients on long‐term glucocorticoids

By  

AUSTRALASIAN JOURNAL OF DERMATOLOGY, Vol. 56, Iss. 2, 2015-05 ,pp. : 147-148

John Wiley & Sons Inc

Access to resources Recommend Favorite

Secondary prevention program for osteoporotic fractures and long-term adherence to bisphosphonates

By Ojeda-Bruno S.   Naranjo A.   Francisco-Hernández F.   Erausquin C.   Rúa-Figueroa I.   Quevedo J.   Rodríguez-Lozano C.  

Osteoporosis International, Vol. 22, Iss. 6, 2011-06 ,pp. : 1821-1828

Springer Publishing Company

Access to resources Recommend Favorite

Safety of Long-Term Administration of Bisphosphonates in Elderly Cancer Patients

By  

Oncology, Vol. 67, Iss. 2, 2004-10 ,pp. : 112-116

Karger

Access to resources Recommend Favorite